Eckert & Ziegler SE

Profile narrative

Eckert & Ziegler SE is a German‑based company that develops, manufactures and distributes radioactive isotopes and radiation sources for medical, industrial and research applications. Its product portfolio includes brachytherapy seeds, gamma‑irradiation sources, radiopharmacy kits, calibration sources and dosimetry systems. The company supplies hospitals, nuclear medicine centres, industrial radiography firms and research laboratories across Europe, North America and Asia. Its services also encompass source logistics, regulatory support and custom source design.

The Eckert & Ziegler Group operates through a network of wholly owned subsidiaries and affiliated companies located in Germany, the United States, France, the United Kingdom, the Netherlands and several Asian countries. While the prompt does not disclose exact employee numbers or revenue figures, public filings describe the group as having a global footprint that enables it to serve customers in numerous countries worldwide. The company’s production sites are equipped to handle sealed and unsealed radioactive materials under strict safety and environmental controls. This geographic reach allows it to respond quickly to regional demand for isotope‑based technologies.

A distinguishing attribute of Eckert & Ziegler is its deep specialization in isotope technology, which positions it as a supplier of both standard and custom‑made radioactive sources that meet stringent international regulations such as those set by the IAEA, EURATOM and national nuclear authorities. The firm maintains in‑house capabilities for isotope production, source encapsulation, quality testing and radiation protection consulting. Its expertise extends to emerging fields like targeted alpha‑therapy and PET‑trace‑metal production, where it collaborates with research institutions and pharmaceutical companies. These competencies are reinforced by a long history of innovation in radiation source design and a commitment to continuous improvement of safety protocols.

Structurally, Eckert & Ziegler SE serves as the parent company of the Eckert & Ziegler Group, which comprises multiple operating subsidiaries that focus on specific business lines such as medical isotopes, industrial radiation sources and dosimetry. The SE is listed on the Frankfurt Stock Exchange under the ticker EZAG, making it a publicly traded entity subject to German corporate governance rules. Ownership is therefore dispersed among institutional and retail investors, while the executive board oversees group strategy and the incident response described in the prompt. The company’s governance framework includes audit, risk and compliance committees that support its operational resilience and adherence to legal obligations. In February 2025 the company disclosed a cyber attack that affected parts of its IT systems, leading to a temporary shutdown of those systems and the formation of a task force with external cyber‑security and forensic specialists to investigate and restore operations.

Incidents

1 incident linked to this organisation.